{"transactions":[{"id":1253122,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":82913,"kind":"person","name":"Arnold Mitchell","position":1,"cik":"0001841497","reported_name":"Arnold Mitchell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-02-21T22:34:57.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of restricted shares of common stock, par value $0.0001 per share, of the Issuer granted under the Petros Pharmaceuticals, Inc. Amended and Restated 2020 Omnibus Incentive Compensation Plan, as amended. 50% of the shares vest on the first anniversary of the date of grant and the remaining shares vest on the second anniversary on the date of grant, provided that the Reporting Person continues to provide service to the Issuer on the applicable vesting date."}],"balance_after":150000,"source":{"system":"sec-edgar","filing":"0001104659-25-016202","document":"tm257316-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465925016202/tm257316-4_4seq1.xml","form_type":"4"}},{"id":1700178,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":82913,"kind":"person","name":"Arnold Mitchell","position":1,"cik":"0001841497","reported_name":"Arnold Mitchell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-26T22:06:56.000Z","date":"2023-12-21","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vested 100% upon grant."}],"balance_after":20000,"derivative":{"exercise_price":1.41,"expiration_date":"2033-12-21","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-23-129251","document":"tm2333705-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465923129251/tm2333705-5_4seq1.xml","form_type":"4"}},{"id":2613156,"issuer":{"id":8730,"kind":"organization","name":"Petros Pharmaceuticals, Inc."},"owners":[{"id":82913,"kind":"person","name":"Arnold Mitchell","position":1,"cik":"0001841497","reported_name":"Arnold Mitchell","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Prin. Acct. Off/Prin. Fin. Off"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-05T22:02:37.000Z","date":"2021-05-11","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the options vested 30% on the date of grant, 30% shall vest upon the first annual anniversary of the date of grant and 40% shall vest upon the second annual anniversary of the date of grant."}],"balance_after":50000,"derivative":{"exercise_price":3.21,"expiration_date":"2031-05-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001567619-21-014526","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815903/000156761921014526/doc1.xml","form_type":"4"}}]}